Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "gastrointestinal transit/bulk-forming effect" refers not to a specific molecular target but rather to the physiological action produced by certain types of laxatives—primarily dietary fibers known as bulk-forming agents. These substances are indigestible hydrophilic colloids that absorb water within the gut lumen, forming a viscous gel that increases both the volume and softness of stools. This increased mass stretches the colonic wall, stimulating peristalsis through mechanical means rather than direct receptor-mediated signaling. Commonly used for prevention—and not acute treatment—of functional constipation, these agents require adequate fluid intake for safety and efficacy. They are generally well-tolerated but can cause bloating or gas due to fermentation by colonic bacteria; rare complications include intestinal obstruction if used improperly or without sufficient hydration. Examples include psyllium husk, methylcellulose, polycarbophil, wheat bran, among others. Note: "Gastrointestinal transit/bulk-forming effect" is not itself a canonical drug target such as an enzyme or receptor; it describes a pharmacodynamic outcome mediated by physical properties rather than interaction with specific molecular targets.
Bulk-forming agents are indigestible hydrophilic colloids that absorb water in the intestine, swell to form a gel-like mass, and increase stool volume. This distends the colon wall and stimulates peristaltic activity by mechanical stretch. The increased bulk also supports bacterial growth in the colon which further contributes to fecal mass. The net result is enhanced gastrointestinal transit and easier passage of stool
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bulk-forming laxative effect on gastrointestinal transit (null).